Andrew Combs

Andrew Combs

Corporate Officer/Principal at PRELUDE THERAPEUTICS INCORPORATED

Net worth: - $ as of 2024-04-29

58 year
Health Technology
Consumer Services

Profile

Andrew P.
Combs
is currently the Executive Vice President & Head-Chemistry at Prelude Therapeutics, Inc. He was previously the Vice President at Incyte Corp.
Prior to that, he held Director-Medicinal Chemistry positions at DuPont Pharmaceuticals Co. and DuPont Merck Pharmaceutical Co. and was also the Director-Medicinal Pharmaceuticals at Bristol Myers Squibb Co. Combs holds a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of Wisconsin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-29 0 ( -.--% ) - $ 2024-04-29

Andrew Combs active positions

CompaniesPositionStart
PRELUDE THERAPEUTICS INCORPORATED Corporate Officer/Principal 2019-03-31
All active positions of Andrew Combs

Former positions of Andrew Combs

CompaniesPositionEnd
INCYTE CORPORATION Director of Finance/CFO 2014-12-31
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 2002-12-31
Corporate Officer/Principal 2002-07-31
Corporate Officer/Principal 2002-07-31
See the detail of Andrew Combs's experience

Training of Andrew Combs

University of Wisconsin Undergraduate Degree
University of California, Los Angeles Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Combs's experience

Connections

99

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
PRELUDE THERAPEUTICS INCORPORATED

Health Technology

INCYTE CORPORATION

Health Technology

BRISTOL-MYERS SQUIBB COMPANY

Health Technology

Private companies2

Health Technology

Health Technology

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW